164 related articles for article (PubMed ID: 29617381)
21. Topical polyethylene glycol as a novel chemopreventive agent for oral cancer via targeting of epidermal growth factor response.
Wali RK; Kunte DP; De La Cruz M; Tiwari AK; Brasky J; Weber CR; Gibson TP; Patel A; Savkovic SD; Brockstein BE; Roy HK
PLoS One; 2012; 7(6):e38047. PubMed ID: 22675506
[TBL] [Abstract][Full Text] [Related]
22. Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial.
Higurashi T; Takahashi H; Endo H; Hosono K; Yamada E; Ohkubo H; Sakai E; Uchiyama T; Hata Y; Fujisawa N; Uchiyama S; Ezuka A; Nagase H; Kessoku T; Matsuhashi N; Yamanaka S; Inayama Y; Morita S; Nakajima A
BMC Cancer; 2012 Mar; 12():118. PubMed ID: 22443173
[TBL] [Abstract][Full Text] [Related]
23. Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats.
Corpet DE; Parnaud G
Carcinogenesis; 1999 May; 20(5):915-8. PubMed ID: 10334212
[TBL] [Abstract][Full Text] [Related]
24. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
25. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications.
DiPalma JA; Cleveland MB; McGowan J; Herrera JL
South Med J; 2007 Nov; 100(11):1085-90. PubMed ID: 17984738
[TBL] [Abstract][Full Text] [Related]
26. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
Dipalma JA; Cleveland MV; McGowan J; Herrera JL
Am J Gastroenterol; 2007 Jul; 102(7):1436-41. PubMed ID: 17403074
[TBL] [Abstract][Full Text] [Related]
27. Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension.
Nakajima A; Shinbo K; Oota A; Kinoshita Y
J Gastroenterol; 2019 Sep; 54(9):792-803. PubMed ID: 31011797
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Low Doses of Acetylsalicylic Acid on the Occurrence of Rectal Aberrant Crypt Foci.
Kowalczyk M; Sigorski D; Dyśko Ł; Zieliński E; Zupanovich Lucka D; Klepacki Ł
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556972
[TBL] [Abstract][Full Text] [Related]
29. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
[TBL] [Abstract][Full Text] [Related]
30. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
Cinca R; Chera D; Gruss HJ; Halphen M
Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
[TBL] [Abstract][Full Text] [Related]
31. Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens.
Corpet DE; Parnaud G; Delverdier M; Peiffer G; Taché S
Cancer Res; 2000 Jun; 60(12):3160-4. PubMed ID: 10866305
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
[TBL] [Abstract][Full Text] [Related]
33. Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats.
Parnaud G; Taché S; Peiffer G; Corpet DE
Cancer Res; 1999 Oct; 59(20):5143-7. PubMed ID: 10537289
[TBL] [Abstract][Full Text] [Related]
34. Lubiprostone plus PEG electrolytes versus placebo plus PEG electrolytes for outpatient colonoscopy preparation: a randomized, double-blind placebo-controlled trial.
Sofi AA; Nawras AT; Pai C; Samuels Q; Silverman AL
Am J Ther; 2015; 22(2):105-10. PubMed ID: 23846523
[TBL] [Abstract][Full Text] [Related]
35. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation.
Corazziari E; Badiali D; Habib FI; Reboa G; Pitto G; Mazzacca G; Sabbatini F; Galeazzi R; Cilluffo T; Vantini I; Bardelli E; Baldi F
Dig Dis Sci; 1996 Aug; 41(8):1636-42. PubMed ID: 8769292
[TBL] [Abstract][Full Text] [Related]
36. Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial.
Bostick RM; Potter JD; Fosdick L; Grambsch P; Lampe JW; Wood JR; Louis TA; Ganz R; Grandits G
J Natl Cancer Inst; 1993 Jan; 85(2):132-41. PubMed ID: 8418302
[TBL] [Abstract][Full Text] [Related]
37. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial.
Ishikawa H; Mutoh M; Suzuki S; Tokudome S; Saida Y; Abe T; Okamura S; Tajika M; Joh T; Tanaka S; Kudo SE; Matsuda T; Iimuro M; Yukawa T; Takayama T; Sato Y; Lee K; Kitamura S; Mizuno M; Sano Y; Gondo N; Sugimoto K; Kusunoki M; Goto C; Matsuura N; Sakai T; Wakabayashi K
Gut; 2014 Nov; 63(11):1755-9. PubMed ID: 24488498
[TBL] [Abstract][Full Text] [Related]
38. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
[TBL] [Abstract][Full Text] [Related]
39. Single-dose lubiprostone along with split-dose PEG solution without dietary restrictions for bowel cleansing prior to colonoscopy: a randomized, double-blind, placebo-controlled trial.
Stengel JZ; Jones DP
Am J Gastroenterol; 2008 Sep; 103(9):2224-30. PubMed ID: 18684185
[TBL] [Abstract][Full Text] [Related]
40. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.
Carroll RE; Benya RV; Turgeon DK; Vareed S; Neuman M; Rodriguez L; Kakarala M; Carpenter PM; McLaren C; Meyskens FL; Brenner DE
Cancer Prev Res (Phila); 2011 Mar; 4(3):354-64. PubMed ID: 21372035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
